These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

982 related items for PubMed ID: 25625421

  • 1. Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy.
    Ji WH, Jiang YH, Ji YL, Li B, Mao WM.
    Dis Esophagus; 2016 Jul; 29(5):403-11. PubMed ID: 25625421
    [Abstract] [Full Text] [Related]

  • 2. The Preoperative Neutrophil-To-Lymphocyte Ratio Is a Novel Immune Parameter for the Prognosis of Esophageal Basaloid Squamous Cell Carcinoma.
    Xiao Q, Zhang B, Deng X, Wu J, Wang H, Wang Y, Wang W.
    PLoS One; 2016 Jul; 11(12):e0168299. PubMed ID: 27959959
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer.
    Xie X, Luo KJ, Hu Y, Wang JY, Chen J.
    Dis Esophagus; 2016 Jan; 29(1):79-85. PubMed ID: 25410116
    [Abstract] [Full Text] [Related]

  • 4. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.
    Duan H, Zhang X, Wang FX, Cai MY, Ma GW, Yang H, Fu JH, Tan ZH, Meng YQ, Fu XY, Ma QL, Lin P.
    World J Gastroenterol; 2015 May 14; 21(18):5591-7. PubMed ID: 25987784
    [Abstract] [Full Text] [Related]

  • 5. Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
    Zhou XL, Li YQ, Zhu WG, Yu CH, Song YQ, Wang WW, He DC, Tao GZ, Tong YS.
    Sci Rep; 2017 Feb 14; 7():42581. PubMed ID: 28195186
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of the prognostic nutritional index in esophageal cancer patients undergoing neoadjuvant chemotherapy.
    Nakatani M, Migita K, Matsumoto S, Wakatsuki K, Ito M, Nakade H, Kunishige T, Kitano M, Kanehiro H.
    Dis Esophagus; 2017 Aug 01; 30(8):1-7. PubMed ID: 28575242
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after radical resection of esophageal squamous cell carcinoma].
    Chen H, He J.
    Zhonghua Zhong Liu Za Zhi; 2014 Apr 01; 36(4):294-7. PubMed ID: 24989917
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Neutrophil to Lymphocyte Ratio as Predictor of Treatment Response in Esophageal Squamous Cell Cancer.
    Barbetta A, Nobel TB, Sihag S, Hsu M, Tan KS, Bains MS, Isbell JM, Janjigian YY, Wu AJ, Bott MJ, Jones DR, Molena D.
    Ann Thorac Surg; 2018 Sep 01; 106(3):864-871. PubMed ID: 29738752
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of preoperative absolute peripheral monocyte count in esophageal squamous cell carcinoma.
    Han L, Jia Y, Song Q, Wang N, Wang J, Bai B, Chen X, Wang C, Cheng Y.
    Dis Esophagus; 2016 Oct 01; 29(7):740-746. PubMed ID: 26316375
    [Abstract] [Full Text] [Related]

  • 12. Does Neutrophil-to-Lymphocyte Ratio (NLR) Predict Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma?
    Anand S, Bhati G, Gurram R, Gnanasekaran S, Kate V, Pottakkat B, Kalayarasan R.
    J Gastrointest Cancer; 2021 Jun 01; 52(2):659-665. PubMed ID: 32607960
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of plasma fibrinogen level as a predictive marker for postoperative recurrence of esophageal squamous cell carcinoma in patients receiving neoadjuvant treatment.
    Matsuda S, Takeuchi H, Fukuda K, Nakamura R, Takahashi T, Wada N, Kawakubo H, Saikawa Y, Omori T, Kitagawa Y.
    Dis Esophagus; 2014 Jun 01; 27(7):654-61. PubMed ID: 23980622
    [Abstract] [Full Text] [Related]

  • 14. Cumulative score based on preoperative plasma fibrinogen and serum C-reactive protein could predict long-term survival for esophageal squamous cell carcinoma.
    Tian R, Yan H, Zhang F, Sun P, Wu AR, Zhang M, Jiang YL, Wu J, Lu YH, Xu QY, Zhan XH, Zhang RX, Qian LT, He J.
    Oncotarget; 2016 Sep 20; 7(38):61533-61543. PubMed ID: 27517497
    [Abstract] [Full Text] [Related]

  • 15. A Novel Prognostic Scoring System Using Inflammatory Response Biomarkers for Esophageal Squamous Cell Carcinoma.
    Hirahara N, Tajima Y, Fujii Y, Yamamoto T, Hyakudomi R, Hirayama T, Taniura T, Ishitobi K, Kidani A, Kawabata Y.
    World J Surg; 2018 Jan 20; 42(1):172-184. PubMed ID: 28744596
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prognostic value of the neutrophil-to-lymphocyte ratio for overall and disease-free survival in patients with surgically treated esophageal squamous cell carcinoma.
    Jung J, Park SY, Park SJ, Park J.
    Tumour Biol; 2016 Jun 20; 37(6):7149-54. PubMed ID: 26662960
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Preoperative neutrophil-lymphocyte ratio before platelet-lymphocyte ratio predicts clinical outcome in patients with cervical cancer treated with initial radical surgery.
    Zhang Y, Wang L, Liu Y, Wang S, Shang P, Gao Y, Chen X.
    Int J Gynecol Cancer; 2014 Sep 20; 24(7):1319-25. PubMed ID: 25033256
    [Abstract] [Full Text] [Related]

  • 20. Prognostic impact of the red cell distribution width in esophageal cancer patients: A systematic review and meta-analysis.
    Xu WY, Yang XB, Wang WQ, Bai Y, Long JY, Lin JZ, Xiong JP, Zheng YC, He XD, Zhao HT, Sang XT.
    World J Gastroenterol; 2018 May 21; 24(19):2120-2129. PubMed ID: 29785080
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.